Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response

Gastroenterology

Volumn 144, Issue 2, 2013, Pages

  Correale, Carmen ^a   Genua, Marco ^a   Vetrano, Stefania ^a   Mazzini, Elisa ^b   Martinoli, Chiara ^b   Spinelli, Antonino ^a   Arena, Vincenzo ^c   Peyrin Biroulet, Laurent ^d   Caprioli, Flavio ^e   Passini, Nadia ^f   Panina Bordignon, Paola ^g   Repici, Alessandro ^a   Malesci, Alberto ^a   Rutella, Sergio ^h   Rescigno, Maria ^b   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITÉ DE LORRAINE   (France)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f BioXell SpA   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Crohn's disease; Immune response; Mouse model; Ulcerative colitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; FLAGELLIN; GAMMA INTERFERON; GELATINASE B; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OVALBUMIN; STROMELYSIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN; TREM2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERICIDAL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EVALUATION STUDY; EXPERIMENTAL COLITIS; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; COLON; COMPARATIVE STUDY; DISEASE MODEL; ENTERITIS; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; COLON; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; RECEPTORS, IMMUNOLOGIC;

EID: 84881191683     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.10.040     Document Type: Article

References (32)

1. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164:4991-4995.
2. Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006;7:1266-1273.
3. Daws MR, Lanier LL, Seaman WE, et al. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol 2001;31:783-791.
4. Turnbull IR, Gilfillan S, Cella M, et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 2006;177:3520-3524.
5. Cella M, Buonsanti C, Strader C, et al. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med 2003;198: 645-651.
6. Kiialainen A, Hovanes K, Paloneva J, et al. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol Dis 2005;18:314-322.
7. Piccio L, Buonsanti C, Mariani M, et al. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007;37:1290-1301.
8. Schmid CD, Sautkulis LN, Danielson PE, et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 2002;83:1309-1320.
9. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005;201:647-657.
10. Daws MR, Sullam PM, Niemi EC, et al. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol 2003;171:594-599.
11. N'Diaye EN, Branda CS, Branda SS, et al. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol 2009;184:215-223.
12. Paloneva J, Mandelin J, Kiialainen A, et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 2003;198:669-675.
13. Helming L, Tomasello E, Kyriakides TR, et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal 2008;1:ra11.
14. Hamerman JA, Jarjoura JR, Humphrey MB, et al. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006;177:2051-2055.
15. Bouchon A, Hernandez-Munain C, Cella M, et al. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001;194:1111-1122.
16. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009;119:2441-2450.
17. Strober W, Kitani A, Fuss I, et al. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol 2008;1(Suppl 1):S5-S9.
18. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
19. Zhang H, Massey D, Tremelling M, et al. Genetics of inflammatory bowel disease: clues to pathogenesis. Br Med Bull 2008; 87:17-30.
20. Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006;130:2060-2073.
21. Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol 2012;42:176-185.
22. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol;28:573-621.
23. Rutella S, Locatelli F. Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2011;17:3761-3775.
24. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009;21:38-46.
25. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008;213:701-713.
26. Danese S, Sans M, Scaldaferri F, et al. TNF-alpha blockade downregulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006;176:2617-2624.
27. Vetrano S, Rescigno M, Cera MR, et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008;135:173-184.
28. Danese S, Scaldaferri F, Vetrano S, et al. Critical role of the CD40 CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut 2007;56:1248-1256.
29. Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998;114:385-391.
30. McCafferty DM, Miampamba M, Sihota E, et al. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864-873.
31. Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103= dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/ T effector cell balance and oral tolerance induction. Gut 2010; 59:595-604.
32. Rotta G, Matteoli G, Mazzini E, et al. Contrasting roles of SPARCrelated granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity. J Exp Med 2008;205:657-667.